On Friday, C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW)’s shares inclined 1.31% to $64.18.
C.H. Robinson Worldwide, Inc. (CHRW) declared that its Board of Directors recently declared a regular quarterly cash dividend of 38 cents ($0.38) per share, payable on June 30, 2015, to shareholders of record on June 5, 2015.
C.H. Robinson has distributed regular dividends for more than twenty-five years. As of May 7, 2015, there were about 145,837,224 shares outstanding.
C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide.
PROFILE
Chimera Investment Corporation (NYSE:CIM)’s shares dropped -1.34% to $14.00.
Chimera Investment Corporation (CIM) effected a one-for-five reverse stock split of its common stock (the “Reverse Stock Split”). In connection with the Reverse Stock Split, effective as of 5:01 p.m. EST on April 6, 2015, every five shares of Chimera’s issued and outstanding common stock converted into one share of Chimera’s common stock. In connection with the Reverse Stock Split, Chimera is voluntarily filing this Current Report on Form 8-K to present certain selected financial data which reflects the effect of the Reverse Stock Split for the years ended December 31, 2014, 2013, 2012, 2011 and 2010. The selected financial information should be read in conjunction with Chimera’s merged financial statements and the notes thereto and “Administration’s Talk about and Analysis of Financial Condition and Results of Operations” in the company’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q for the periods
Chimera Investment Corporation operates as a real estate investment trust in the United States. The company, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes. Its targeted asset classes comprise non-agency RMBS, such as investment-grade and non-investment grade classes; agency RMBS; interest-only RMBS; and first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, and industrial properties.
At the end of Friday’s trade, ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)‘s shares surged 2.80% to $9.90.
Intrexon Corporation (XON), a leader in synthetic biology, recently declared that it has determined the final distribution ratio regarding its formerly declared distribution of all of its 17,830,305 shares of ZIOPHARM Oncology, Inc. (“ZIOPHARM”) (ZIOP) common stock on or about June 12, 2015, the distribution date, as a pro rata dividend on shares of Intrexon common stock, and on warrants to purchase shares of Intrexon common stock (“Warrants”), outstanding on June 4, 2015, the record date.
Based on the number of Intrexon shares outstanding and shares deliverable under Warrants as of the record date, holders of Intrexon common stock will receive 0.162203 shares of ZIOPHARM common stock in the distribution with respect to each outstanding share of Intrexon common stock they own at the close of business on the record date, and holders of Warrants will receive 0.162203 shares of ZIOPHARM common stock in the distribution with respect to each share of Intrexon common stock deliverable under the Warrants they hold at the close of business on the record date.
ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Its synthetic immuno-oncology programs, in partnership with Intrexon Corporation and the MD Anderson Cancer Center, comprise chimeric antigen receptor T cell (CAR-T) and other adoptive cell based approaches that use both non-viral and viral gene transfer methods for broad scalability.
Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP), ended its Friday’s trading session with 1.33% gain, and closed at $76.07.
Ctrip.com International, Ltd. (ADR) (CTRP) declared that it is no longer interested in pursuing a potential M&A talk about with Qunar Cayman Islands Limited (QUNR), given Qunar’s recent earnings performance and corporate actions. After being approached by Qunar, Ctrip sent a confidential, non-binding, preliminary proposal to Qunar’s board of directors in early May indicating its interest in pursuing a potential transaction with Qunar. Ctrip received a response from Qunar earlier this week stating that the proposal was not accepted and indicating that Qunar would be open to having further talk about.
Ctrip is confident about its future and its ability to continue to be the most profitable, the largest and fast growing OTA in China based on its years of experiences, innovation and strong operation capability. Ctrip is a long-term player in the OTA market, and has the ability, resource, determination and patience to extend its leadership for many years to come. Meanwhile, Ctrip will continue to explore other partnership opportunities that will bring planned value in the Internet and e-commerce space.
Ctrip.com International, Ltd., together with its auxiliaries, provides travel services for hotel accommodations, transportation ticketing services, packaged tours, and corporate travel administration in the People’s Republic of China. It also offers independent leisure travelers bundled packaged-tour products, counting group tours, semi-group tours, and private tours or packaged tours with various transportation arrangements, such as cruise, bus, or self-driving.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
